Reducing Sedentary Time for Leukemia
(ReSeT in ALL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help adolescents and young adults with acute lymphoblastic leukemia (ALL) undergoing maintenance chemotherapy reduce their sedentary time, which is time spent sitting or lying down without activity. Participants will use a fitness tracker that reminds them to move, engage in coaching sessions, and join a peer support group. These activities form part of the sedentary time intervention to determine if they encourage more activity. Researchers aim to discover whether this program not only reduces sedentary time but also improves quality of life and health markers like inflammation and metabolism. Those sitting for 4+ hours a day during leisure time and undergoing maintenance chemotherapy for ALL might find this trial suitable. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance the well-being of others in similar situations.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. It focuses on reducing sedentary time for those receiving maintenance chemotherapy.
What prior data suggests that this mobile health intervention is safe for adolescents and young adults with acute lymphoblastic leukemia?
Research has shown that using a fitness tracker with reminders to move is generally easy and safe. In past studies, people used these devices without major problems. For example, one study found that participants regularly walked more than 10,000 steps each week with a fitness tracker, suggesting these devices are safe and easy to use.
Additionally, other studies have used mobile health tools like apps and fitness trackers without serious side effects. These tools help people become more active and have been safely used by various groups, including those with cancer.
Overall, research indicates that using a fitness tracker with reminders to move does not pose significant safety risks. Participants in these studies usually find the devices helpful in increasing their activity levels.12345Why are researchers excited about this trial?
Researchers are excited about the sedentary time intervention for leukemia patients because it focuses on a novel approach: reducing inactivity. Unlike traditional treatments for leukemia, which primarily involve chemotherapy, radiation, or targeted therapy, this intervention aims to improve patient outcomes by encouraging more physical activity. This method could enhance patients' overall health and quality of life, potentially reducing fatigue and improving mental well-being. By shifting focus from medication to lifestyle changes, it opens new avenues for supportive care in leukemia treatment.
What evidence suggests that this mobile health intervention is effective for reducing sedentary time in adolescents and young adults with acute lymphoblastic leukemia?
Research shows that wearable fitness trackers can help people sit less. Previous studies have indicated that these devices motivate people to move more, improving their health. One study found that fitness trackers helped children with acute lymphoblastic leukemia (ALL) become more active and feel less tired. Another review demonstrated that these trackers effectively increase physical activity and improve health in cancer patients. In this trial, participants will receive a sedentary time intervention, which includes a fitness tracker, reminders, coaching, and support from others, to help young people with ALL sit less and feel better.46789
Who Is on the Research Team?
Brittany J Ivory (Van Remortel), MD, MPH
Principal Investigator
Children's Hospital Los Angeles
Are You a Good Fit for This Trial?
This trial is for adolescents aged 12-18 with acute lymphoblastic leukemia who are sedentary, spending on average 8+ hours a day sitting or lying down. They must have completed at least one cycle of maintenance chemotherapy and be willing to reduce their sedentary time. Participants need internet access, a smartphone compatible with Fitbit and WhatsApp, and speak English fluently.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a multi-component mobile health intervention including a wearable fitness tracker, individualized coaching sessions, and an app-based peer support group to decrease sedentary time over 10 weeks.
Follow-up
Participants are monitored for changes in sedentary time, quality of life, and metabolic markers post-intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Sedentary time intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Los Angeles
Lead Sponsor
St. Baldrick's Foundation
Collaborator
Rally Foundation for Childhood Cancer Research
Collaborator